{"id":775187,"date":[{"year":1988,"month":7,"day":26}],"page":"2","source":"本报","region":"","masthead":"综合新闻","special_issue":"","column":"","genre":"","count":"218","ytitle":"","mtitle":"酶联雌二醇法可提供乳腺癌手术预后情况","ftitle":"","authors":["陈雨农"],"text":[{"type":"paragraph","text":"本报讯　乳腺癌患者很希望了解自己的预后，医生也想了解病人术后采取什么样的辅助治疗方法最理想。现在，上海医科大学肿瘤医院病理科刘尚廉教授和上海生化所姚连生工程师等在国内最早采用的酶联雌二醇法可实现这个愿望。这种检测方法比较简便。在乳腺癌切除后，立即取癌组织制成冰冻切片，滴加辣根过氧化物酶标记的雌二醇及孕酮，即能显示不同颜色，从而判断出预后好差，临床医师就可据此选用最佳治疗方案。　(陈雨农)"}]}